FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PREDICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT
Petra Anna Golovics 1
Barbara Dorottya Lovasz 1
Zsuzsanna Kürti 2
Mariann Rutka
Zsuzsanna Vegh
Krisztina Barbara Gecse
Klaudia Farkas
János Banai
László Bene
Lorant Gonczi
Beata Gasztonyi
Tünde Kristóf
László Lakatos
Pal Miheller
Karoly Palatka
Árpád V. Patai
Mária Papp
Ágnes Szabone Salamon
Tamás Szamosi
Zo
1 Semmelweis University Faculty of Medicine 1st Dept. of Medicine - 1st Department of Medicine, Semmel,1st Department of Medicine,Budapest,Hungary
2 Semmelweis University Faculty of Medicine 1st D
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]